Menopause Position Statements

“If you would like to find out what menopause
position statements are applicable to you, it may be
in your best interest to choose to talk to your…”.Meno Martha

Umbrella
What may the Menopause Position Statements Umbrella include?

Depending on the Source (DotS) this Umbrella may include:

  • Clinical Guides
  • Consensus Statements
  • Final Recommendation Statements
  • Global Consensus Statements
  • Guidelines
  • Other Reports
  • Position Papers
  • Position Statements
  • Recommendations
  • Reports
  • Statements
  • White Paper

Date

Menopause Position StatementsWhat can it be important to be clear about with menopause position statements?

It can be important to be clear about the date of all information including the date of menopause position statements because this information may have been updated or retired.

Health Care Provider

What if I would like to find out what menopause position statement information is applicable to me?

If you would like to find out what menopause position statements are applicable to you, it may be in your best interest to choose to talk to your health care provider about this.

Health Topics A-Z

Where may I find Health Topics A-Z related to Menopause Position Statements?

In Health Topics A-Z you may find:

Health Topics A-Z

Links

Where may I find Links related to Menopause Position Statements?

Your Country may have Links similar to:

Links

This Links List to third party websites is neither comprehensive nor exhaustive. Inclusion on this Links List does not imply endorsement or recommendation. Non-inclusion on this Links List does not imply non-endorsement or non-recommendation. Third party websites are not under the control of Meno Martha International Menopause Directory. Third party websites may contain explicit medical images and/or sexual references. Please read Meno Martha International Menopause Directory’s Links Policy before proceeding to a Link. Please contact Webmaster if you experience a problem with a Link.

BMS   = British Menopause Society
EMAS = European Menopause and Andropause Society
IGCS  = International Gynecologic Cancer Society
IMS    = International Menopause Society

New or Updated

  1. Assessment and Management of Bone Health In Women With Oestrogen Receptor-Positive Breast Cancer Receiving Endocrine Therapy
  2. BMS & WHC’s 2020 Recommendations on Hormone Replacement Therapy In Menopausal Women
  3. BMS Council Issues A Consensus Statement on Bioidentical Hormones
  4. BMS Statement on Testosterone
  5. BMS Vision: Vision for Menopause Care In the United Kingdom
  6. BMS, IMS, EMAS, RCOG and AMS Joint Statement on Menopausal Hormone Therapy (MHT) and Breast Cancer Risk
  7. Bioidentical HRT [British Menopause Society]
  8. British Menopause Society Tool for Clinicians: Testosterone Replacement In Menopause
  9. Calcium In the Prevention of Postmenopausal Osteoporosis: EMAS Guide
  10. Cardiovascular Health After Menopause Transition, Pregnancy Disorders, and Other Gynaecologic Conditions: A Consensus Document From European Cardiologists, Gynaecologists, and Endocrinologists
  11. Cardiovascular Risk Assessment In Women – An Update
  12. Clinical Practice Guidelines on Menopause: *An Executive Summary and Recommendations: Indian Menopause Society 2019–2020
  13. Clinical Practice Guidelines on Postmenopausal Osteoporosis: *An Executive Summary and Recommendations – Update 2019–2020 [Indian Menopause Society]
  14. Compounded Bioidentical Hormones In Endocrinology Practice: An Endocrine Society Scientific Statement
  15. Current Management of Pelvic Organ Prolapse In Aging Women: EMAS Clinical Guide
  16. Department of Health Shares the Results of Research About Menopause In Ireland Following the First Government Led Menopause Awareness Campaign In Ireland
  17. Drug Holidays From Bisphosphonates and Denosumab In Postmenopausal Osteoporosis
  18. EMAS Position Statement: Predictors of Premature and Early Natural Menopause
  19. EMAS Position Statement: Vitamin D and Menopausal Health
  20. Eligibility Criteria for Menopausal Hormone Therapy (MHT): A Position Statement From A Consortium of Scientific Societies for the Use of MHT In Women With Medical Conditions. MHT Eligibility Criteria Group
  21. Global Consensus Position Statement on the Use of Testosterone Therapy for Women
  22. Global Consensus Recommendations on Menopause In the Workplace: A European Menopause and Andropause Society (EMAS) Position Statement
  23. Global Consensus Statement on Menopausal Hormone Therapy
  24. Guidelines and Education: EMAS Position Statements
  25. Guidelines for the Evaluation and Treatment of Perimenopausal Depression: Summary and Recommendations
  26. Hormone Therapy In Postmenopausal Persons: Primary Prevention of Chronic Conditions
  27. Info for Professionals: Clinical Practice Guidelines [Indian Menopause Society]
  28. International Society for the Study of Women’s Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder In Women
  29. Joint BMS, FSRH, RCGP and RCOG Position Statement on the Supply Shortages of Hormone Replacement Therapy (HRT)
  30. Joint Position Statement by the British Menopause Society, Royal College of Obstetricians and Gynaecologists and Society for Endocrinology on Best Practice Recommendations for the Care of Women Experiencing the Menopause
  31. Management of Osteoporosis In Postmenopausal Women: The 2021 Position Statement of The North American Menopause Society
  32. Management of Postmenopausal Women: Collège National des Gynécologues et Obstétriciens Français (CNGOF) and Groupe d’Etude sur la Ménopause et le Vieillissement (GEMVi) Clinical Practice Guidelines
  33. Menopause Knowledge and Education In Women Under 40: Results From An Online Survey
  34. Menopause and Diabetes: EMAS Clinical Guide
  35. Menopause, Wellbeing and Health: A Care Pathway From the European Menopause and Andropause Society
  36. Menopause: Diagnosis and Management [NICE Guideline In Development [GID-NG10241] Expected Publication Date: 23 August 2023]
  37. Menopause: Diagnosis and Management [NICE Guideline NG 23]
  38. NICE Sets Out Further Details on Menopause Guideline Update
  39. New Menopause Practice Standards
  40. NonHormonal Management of Menopause-Associated Vasomotor Symptoms: 2015 Position Statement of the North American Menopause Society
  41. Optimising the Menopause Transition: Joint Position Statement By the British Menopause Society, Royal College of Obstetricians and Gynaecologists and Society for Endocrinology on Best Practice Recommendations for the Care of Women Experiencing the Menopause
  42. Pharmacological Management of Osteoporosis In Postmenopausal Women Guideline Resources
  43. Position Papers and Consensus Statements [International Menopause Society]
  44. Position Statement on Improving Bone Health and Osteoporosis Management In Australia
  45. Position Statements & Other Reports [North American Menopause Society]
  46. Position Statements [Australasian Menopause Society]
  47. Premature Ovarian Insufficiency [British Menopause Society]
  48. Preventing Obesity in Midlife Women: A Recommendation From the Women’s Preventive Services Initiative
  49. Prevention and Treatment of Osteoporosis In Women [British Menopause Society]
  50. Primary Prevention of Coronary Heart Disease In Women [British Menopause Society]
  51. RCGP, RCOG and BMS Position Statement on the Menopause
  52. Revised Global Consensus Statement on Menopausal Hormone Therapy
  53. The 2020 Genitourinary Syndrome of Menopause Position Statement of The North American Menopause Society
  54. The 2022 Hormone Therapy Position Statement of The North American Menopause Society
  55. The 2023 Nonhormone Therapy Position Statement of The North American Menopause Society
  56. The British Menopause Society & Women’s Health Concern 2020 Recommendations on Hormone Replacement Therapy In Menopausal Women
  57. The Essential Menopause Curriculum for Healthcare Professionals: A European Menopause and Andropause Society (EMAS) Position Statement
  58. The Mediterranean Diet and Menopausal Health: An EMAS Position Statement
  59. The North American Menopause Society Releases Its 2022 Hormone Therapy Position Statement
  60. The Silence and the Stigma: Menopause In Canada
  61. The South African Menopause Society (SAMS) Statement on Compounded (Bioidentical) Menopausal Hormone Therapy
  62. Topical Estrogens and Non-Hormonal Preparations for Postmenopausal Vulvovaginal Atrophy: An EMAS Clinical Guide
  63. Use of Compounded Hormone Therapy In the United States: Report of the North American Menopause Society Survey
  64. Video Series-2023: NAMS 2023 Nonhormone Therapies Position Statement for Bothersome Menopause Symptoms
  65. World Menopause Day 2018 – Sexual Well-Being After Menopause: An International Menopause Society White Paper [Multiply Languages]
  66. World Menopause Day 2019 – Global Consensus Position Statement on the Use of Testosterone Therapy for Women: A White Paper [Multiply Languages]
  67. World Menopause Day 2020: Premature Insufficiency: An International Menopause Society White Paper [Multiply Languages]
  68. World Menopause Day 2021: Update on Bone Health: The IMS White Paper [Multiply Languages]
  69. World Menopause Day: Brain Fog In Menopause: A Health Care Professional’s Guide for Decision Making and Counselling on Cognition: The IMS White Paper

Topic Last Updated: 27 November 2023 – Topic Last Reviewed: 11 November 2023
Print Friendly, PDF & Email
/by